Robert F. Williamson III - 28 Mar 2025 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role: Director
Signature: /s/ Robert F. Williamson, III by Chris Nenno, as Attorney-in-Fact
Issuer symbol: CATX
Transactions as of: 28 Mar 2025
Net transactions value: +$132,151
Form type: 4
Filing time: 01 Apr 2025, 17:04:49 UTC
Previous filing: 05 Mar 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CATX	Common Stock	Purchase	$50,376	+22,192	+46%	$2.27	70,837	28 Mar 2025	Direct
transaction	CATX	Common Stock	Purchase	$81,775	+38,145	+54%	$2.14	108,982	31 Mar 2025	Direct	F1
holding	CATX	Common Stock						366	28 Mar 2025	By RFW3 Revocable Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.12 to $2.1697, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transaction described in this footnote.

Content

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.12 to $2.1697, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transaction described in this footnote.